Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05784961
NA

Impact of tDCS on Cannabis Craving in Schizophrenia

Sponsor: Centre hospitalier de Ville-Evrard, France

View on ClinicalTrials.gov

Summary

This study aims to evaluate the tDCS's impact on cannabis craving in patients with schizophrenia and cannabis addiction disorder.

Official title: Impact of tDCS on Cannabis Craving in Patients With Schizophrenia and Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

138

Start Date

2024-03-01

Completion Date

2027-06-20

Last Updated

2024-02-16

Healthy Volunteers

No

Interventions

DEVICE

tDCS

tDCS will be delivered using this electrode montage: anode on the left dosolateral prefrontal cortex (L DLPFC) using F3 EEG landmark and cathode on the left temporoparietal junction (L TPJ) on the middle point between T3 and P3 EEG landmark. The stimulation will be delivered at an intensity of 2 milliamps, for 20 minutes, five times a day, with 20 min inter sessions (it will be carried out on 5 consecutive days from Monday to Friday). Each processing day corresponds to a visit of V2, V3, V4, V5 and V6.

Locations (2)

Ch Ville Evrard

Neuilly-sur-Marne, France

Youcef Bencherif

Neuilly-sur-Marne, France